Conference Coverage

Diabetes prevention diet may lower mortality risk in breast cancer


 

FROM SABCS 2020

Will patients do what’s good for them?

While this study adds to the body of evidence linking diet and cancer, putting the information into action is another story, according to Halle Moore, MD, of the Cleveland Clinic, who was not involved in this study.

“We have had supportive data for the role of diet in general health outcomes, including cancer-related outcomes, for a long time. But getting the public to implement these dietary changes is a challenge, so certainly the more convincing data that we have and the more specific we can be with specific types of dietary interventions, it does make it more helpful to counsel patients,” Dr. Moore said in an interview.

She said the finding that dietary change post diagnosis can have a significant effect on lowering both all-cause and breast cancer–specific mortality is compelling evidence for a role of diet in breast cancer outcomes.

In the question-and-answer session following Dr. Wang’s presentation, Hans-Christian Kolberg, MD, from Marienhospital Bottrop at the University of Duisburg-Essen (Germany), echoed the sentiment when he commented, “you have an important result that you did not mention in the conclusion: It is not too late to change diet after breast cancer diagnosis!”

This study was supported, in part, by grants from the National Cancer Institute, Breast Cancer Research Foundations, and Susan G. Komen Breast Cancer Foundations. Dr. Wang, Dr. Moore, and Dr. Kolberg reported no relevant conflicts of interest.

SOURCE: Wang T et al. SABCS 2020, Abstract GS2-09.

Pages

Recommended Reading

New findings on ‘exceptional responders’ to cancer therapies
Breast Cancer ICYMI
Reduced cancer mortality with Medicaid expansion
Breast Cancer ICYMI
Should CTCs guide treatment choice in HR+, HER2– breast cancer?
Breast Cancer ICYMI
Cancer rates on the rise in adolescents and young adults
Breast Cancer ICYMI
SABCS 2020: What’s hot, including a major chemotherapy trial
Breast Cancer ICYMI
NHS England starts pilot trial of blood test for many cancers
Breast Cancer ICYMI
Breast surgery may be a gateway to addictive medication use
Breast Cancer ICYMI
CTCs predict overall survival in metastatic breast cancer
Breast Cancer ICYMI
PENELOPE-B: Palbociclib disappoints in HR+, HER2– breast cancer
Breast Cancer ICYMI
monarchE: Abemaciclib reigns on in high-risk breast cancer
Breast Cancer ICYMI